- Japanese chronic systolic heart failure patients with LVEF = and NYHA II or more
- Patients who receive standard therapy (Angiotensin converting enzyme inhibitors,
angiotensin receptor blockers, beta-blocker or diuretic)
- Patients with a myocardial infarction, stroke, cardiac surgery or percutaneous
coronary intervention within 30 days prior to randomization.
- Patients with serum potassium >5.0 mmol/L or eGFR